These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
710 related items for PubMed ID: 14983105
21. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis. Maradit-Kremers H, Nicola PJ, Crowson CS, O'Fallon WM, Gabriel SE. J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365 [Abstract] [Full Text] [Related]
26. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis. Verschueren P, Esselens G, Westhovens R. Rheumatology (Oxford); 2008 Jan; 47(1):59-64. PubMed ID: 18039681 [Abstract] [Full Text] [Related]
27. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis. James HM, Gillis D, Hissaria P, Lester S, Somogyi AA, Cleland LG, Proudman SM. J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994 [Abstract] [Full Text] [Related]
28. Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. Furst DE, Lindsley H, Baethge B, Botstein GR, Caldwell J, Dietz F, Ettlinger R, Golden HE, McLaughlin GE, Moreland LW, Roberts WN, Rooney TW, Rothschild B, Sack M, Sebba AI, Weisman M, Welch KE, Yocum D. Arthritis Rheum; 1999 Feb; 42(2):357-65. PubMed ID: 10025931 [Abstract] [Full Text] [Related]
29. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE. Arthritis Res Ther; 2006 Feb; 8(5):R151. PubMed ID: 16984661 [Abstract] [Full Text] [Related]
30. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial. Sanmartí R, Marsal S, Valverde J, Casado E, Lafuente R, Kashiwagi N, Rodriguez-Cros JR, Erra A, Reina D, Gratacós J. Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997 [Abstract] [Full Text] [Related]
31. The methotrexate therapeutic response in rheumatoid arthritis. Ortendahl M, Holmes T, Schettler JD, Fries JF. J Rheumatol; 2002 Oct; 29(10):2084-91. PubMed ID: 12375316 [Abstract] [Full Text] [Related]
38. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, Racewicz AJ, van Vollenhoven RF, Li NF, Agarwal S, Hessey EW, Shaw TM, DANCER Study Group. Arthritis Rheum; 2006 May 01; 54(5):1390-400. PubMed ID: 16649186 [Abstract] [Full Text] [Related]
39. Remission in rheumatoid arthritis: wishful thinking or clinical reality? Sesin CA, Bingham CO. Semin Arthritis Rheum; 2005 Dec 01; 35(3):185-96. PubMed ID: 16325659 [Abstract] [Full Text] [Related]
40. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis. Lee SS, Park YW, Park JJ, Kang YM, Nam EJ, Kim SI, Lee JH, Yoo WH, Lee SI. Scand J Rheumatol; 2009 Dec 01; 38(1):11-4. PubMed ID: 19191187 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]